AstraZeneca's Covid vaccine, Covishield, has been linked to a rare side effect called Thrombosis with Thrombocytopenia Syndrome (TTS), which can cause blood clots and low platelet count.
While there is a risk of TTS, it is very rare, and not everyone who receives the vaccine will experience it.
Other vaccines like Johnson & Johnson's have also been associated with TTS.
Covishield, widely administered in India, has seen only a limited number of TTS cases reported.
The risk of TTS is mostly post-initial vaccination and has not led to large-scale deaths.
Vaccines are generally safe, with mild side effects being common and serious ones being extremely rare.
People vaccinated with Covishield need not panic, but should consult a doctor if they experience symptoms of TTS.
Overall, claims blaming the Indian government for allowing Covishield and putting people at risk of TTS are exaggerated and misleading.